UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1215-1226

2019

Volltextzugriff (PDF)

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1215-1226

2019

Volltextzugriff (PDF)

Vedolizumab Immunogenicity With Long‐Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease

Journal of clinical pharmacology, 2021-09, Vol.61 (9), p.1174-1181

2021

Volltextzugriff (PDF)

Long‐term safety of vedolizumab for inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2020-10, Vol.52 (8), p.1353-1365

2020

Volltextzugriff (PDF)

Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis

Clinical gastroenterology and hepatology, 2023-02, Vol.21 (2), p.456-466.e7

2023

Volltextzugriff (PDF)

Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)

Gastroenterology (New York, N.Y. 1943), 2021-10, Vol.161 (4), p.1156-1167.e3

2021

Volltextzugriff (PDF)

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply

The New England journal of medicine, 2020-01, Vol.382 (1), p.93-94

2020

Volltextzugriff (PDF)

Management of Upper Gastrointestinal Bleeding in Children: Variceal and Nonvariceal

Gastrointestinal endoscopy clinics of North America, 2016-01, Vol.26 (1), p.63

Lirio, Richard A

2016

Volltextzugriff (PDF)

A hybrid approach of handling missing data under different missing data mechanisms: VISIBLE 1 and VARSITY trials for ulcerative colitis

Contemporary clinical trials, 2021-01, Vol.100, p.106226-106226, Article 106226

2021

Volltextzugriff (PDF)

Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease

Clinical pharmacokinetics, 2021-06, Vol.60 (6), p.811-818

2021

Volltextzugriff (PDF)

Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study

Journal of Crohn's and colitis, 2022-08, Vol.16 (8), p.1243-1254

2022

Volltextzugriff (PDF)

Bowel Preparation for Pediatric Colonoscopy: Report of the NASPGHAN Endoscopy and Procedures Committee

Journal of pediatric gastroenterology and nutrition, 2014-09, Vol.59 (3), p.409-416

2014

Volltextzugriff (PDF)

Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review

Crohn's & colitis 360, 2022-07, Vol.4 (3), p.otac020

2022

Volltextzugriff (PDF)

Sa1664 The First Case Report of Esoflip for Dilation of a Pediatric Esophageal Stricture

Gastrointestinal endoscopy, 2015-05, Vol.81 (5), p.AB299-AB300

2015

Volltextzugriff (PDF)

Management of Upper Gastrointestinal Bleeding in Children

Gastrointestinal endoscopy clinics of North America, 2016-01, Vol.26 (1), p.63-73

Lirio, Richard A.

2016

Volltextzugriff (PDF)

Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases

Clinical pharmacology in drug development, 2021-07, Vol.10 (7), p.734-747

2021

Volltextzugriff (PDF)

416a – Vedolizumab Shows Superior Efficacy Versus Adalimumab: Results of Varsity—The First Head-To-Head Study of Biologic Therapy for Moderate-To-Severe Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-81-S-81

2019

Volltextzugriff (PDF)

NASPGHAN Capsule Endoscopy Clinical Report

Journal of pediatric gastroenterology and nutrition, 2017-03, Vol.64 (3), p.485-494

2017

Volltextzugriff (PDF)

Advances in Pediatric Diagnostic Endoscopy: A State-of-the-Art Review

JPGN reports, 2022-08, Vol.3 (3), p.e224-e224

2022

Volltextzugriff (PDF)

Sa2061 Above and Beyond Training: Colonoscopy Learning Curves and Expected Annual Procedural Volume of Credentialed Pediatric Gastroenterologists

Gastrointestinal endoscopy, 2016-05, Vol.83 (5), p.AB302-AB302

2016

Volltextzugriff (PDF)

Su1929 A HYBRID APPROACH OF HANDLING MISSING DATA IN INFLAMMATORY BOWEL DISEASE (IBD) TRIALS: RESULTS FROM VISIBLE 1 AND VARSITY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-706-S-707

2020

Volltextzugriff (PDF)

Tu1742 – Long-Term Immunogenicity of Intravenous Vedolizumab in Ulcerative Colitis and Crohn's Disease (Gemini Program)

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1107-S-1107

2019

Volltextzugriff (PDF)

225 PROGNOSTIC VALUE OF FECAL CALPROTECTIN IN BIOLOGIC-TREATED PATIENTS WITH ULCERATIVE COLITIS

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-46-S-47

2021

Volltextzugriff (PDF)

Sa1881 A COMPARISON OF EARLY RESPONSE PARAMETERS TO INFORM A TREAT-TO-TARGET APPROACH IN ULCERATIVE COLITIS

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-463-S-464

2020

Volltextzugriff (PDF)

Sa1746 VEDOLIZUMAB DOSE ESCALATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE EXPERIENCING LOSS OF RESPONSE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF REAL-WORLD EVIDENCE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-406-S-407

2020

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(5)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Vedolizumab Immunogenicity With Long‐Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease

Long‐term safety of vedolizumab for inflammatory bowel disease

Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis

Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply

Management of Upper Gastrointestinal Bleeding in Children: Variceal and Nonvariceal

A hybrid approach of handling missing data under different missing data mechanisms: VISIBLE 1 and VARSITY trials for ulcerative colitis

Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease

Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study

Bowel Preparation for Pediatric Colonoscopy: Report of the NASPGHAN Endoscopy and Procedures Committee

Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review

Sa1664 The First Case Report of Esoflip for Dilation of a Pediatric Esophageal Stricture

Management of Upper Gastrointestinal Bleeding in Children

Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases

416a – Vedolizumab Shows Superior Efficacy Versus Adalimumab: Results of Varsity—The First Head-To-Head Study of Biologic Therapy for Moderate-To-Severe Ulcerative Colitis

NASPGHAN Capsule Endoscopy Clinical Report

Advances in Pediatric Diagnostic Endoscopy: A State-of-the-Art Review

Sa2061 Above and Beyond Training: Colonoscopy Learning Curves and Expected Annual Procedural Volume of Credentialed Pediatric Gastroenterologists

Su1929 A HYBRID APPROACH OF HANDLING MISSING DATA IN INFLAMMATORY BOWEL DISEASE (IBD) TRIALS: RESULTS FROM VISIBLE 1 AND VARSITY

Tu1742 – Long-Term Immunogenicity of Intravenous Vedolizumab in Ulcerative Colitis and Crohn's Disease (Gemini Program)

225 PROGNOSTIC VALUE OF FECAL CALPROTECTIN IN BIOLOGIC-TREATED PATIENTS WITH ULCERATIVE COLITIS

Sa1881 A COMPARISON OF EARLY RESPONSE PARAMETERS TO INFORM A TREAT-TO-TARGET APPROACH IN ULCERATIVE COLITIS

Sa1746 VEDOLIZUMAB DOSE ESCALATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE EXPERIENCING LOSS OF RESPONSE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF REAL-WORLD EVIDENCE

Suchergebnisse filtern